Neurolysis

Dr. John and staff believe that informed patients are better equipped to make decisions regarding their health and well being. For your personal use, we have created an extensive patient library covering an array of educational topics. Browse through these diagnoses and treatments to learn more about topics of interest to you. Or, for a more comprehensive search of our entire Web site, enter your term(s) in the search bar provided.

Also visit www.foothealthfacts.org to learn more about what conditions are treated by podiatric foot & ankle surgeons.


 

Many patients ask:

What is the difference between a podiatric surgeon and an orthopedic surgeon?

 

The short answer is that both podiatrists and orthopedists perform surgery on the foot and ankle. This is similar to neurosurgeons and orthopedists both performing back surgery or dermatologists and plastic surgeons both performing cosmetic surgery.

Yet there are some distinctions in choosing a podiatric surgeon for your foot and ankle care:

  • While being the same 4 year length as osteopathic (DO) and allopathic (MD) medical school and covering the same basic and clinical sciences, the podiatric medical school curriculum provides additional intense focus on conditions of the foot, ankle and lower leg.
  • Podiatric surgeons typically complete 3 years of intense residency training in complex foot and ankle surgery. General orthopedists who desire to pursue additional training in foot and ankle surgery typically complete a 1 year fellowship.
  • As Fellows of the American College of Foot & Ankle Surgeons, podiatric surgeons remain among a group of the only physicians who are Board Certified in Foot Surgery and/or Reconstructive Rearfoot Surgery.

 

Neurolysis is a therapeutic procedure used to treat neuromas. During this nonsurgical procedure, the affected nerve is chemically destroyed via seven weekly injections of ethanol mixed with a local anesthetic. Because nerve tissue has an affinity for ethanol, it absorbs the substance, which, after repeated exposure, becomes toxic and destroys the pain-causing nerve. Neurolysis has a success rate of more than 60 percent. However, this treatment modality is not widely accepted by insurance companies.